Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Historical Holders from Q4 2015 to Q3 2025

Symbol
WVE on Nasdaq
CUSIP
Y95308105
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
174M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
144M
Holdings value
$1.05B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
186
Number of buys
92
Number of sells
-79
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 14.6% $186M 25.5M RA Capital Management, L.P. Nov 11, 2025
Adage Capital Management, L.P. 9.65% +18.8% $97.6M $16.3M 15M +20% Adage Capital Management, L.P. Jun 30, 2025
BlackRock, Inc. 6.1% $57.5M 9.36M BlackRock, Inc. Dec 31, 2024
MAVERICK CAPITAL LTD 5.4% $50.7M 8.26M Maverick Capital, Ltd. Dec 31, 2024

Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 144M $1.05B +$37.2M $7.32 186
2025 Q2 139M $903M +$46.4M $6.50 174
2025 Q1 131M $1.06B +$20.3M $8.08 192
2024 Q4 129M $1.59B +$87.8M $12.37 180
2024 Q3 120M $985M +$175M $8.20 159
2024 Q2 93.7M $468M +$9.89M $4.99 142
2024 Q1 92.8M $572M -$444K $6.17 132
2023 Q4 1.37M $7.69M -$132K $5.34 2
2023 Q3 72.6M $417M +$2.96M $5.75 85
2023 Q2 72.1M $263M +$6.6M $3.64 79
2023 Q1 70.1M $303M +$3.71M $4.33 72
2022 Q4 68.1M $477M +$7.47M $7.00 74
2022 Q3 67.1M $242M -$1.79M $3.61 56
2022 Q2 67.7M $220M +$70.1M $3.25 55
2022 Q1 44.5M $89M -$637K $2.00 75
2021 Q4 47.3M $148M +$13.3M $3.14 85
2021 Q3 37.4M $184M +$444K $4.90 84
2021 Q2 37M $247M -$5.82M $6.66 83
2021 Q1 38.3M $215M +$1.49M $5.61 98
2020 Q4 36.1M $284M -$9.58M $7.87 101
2020 Q3 37.1M $316M +$59.3M $8.49 105
2020 Q2 29.4M $306M -$6.7M $10.41 88
2020 Q1 30.1M $282M +$9.44M $9.37 76
2019 Q4 29.2M $234M -$45.1M $8.01 85
2019 Q3 30.9M $634M +$1.15M $20.53 86
2019 Q2 30.2M $788M +$41.4M $26.09 98
2019 Q1 29.4M $1.14B +$192M $38.85 108
2018 Q4 24.4M $1.03B +$23M $42.04 90
2018 Q3 23.8M $1.19B -$29.7M $50.00 92
2018 Q2 24.5M $936M +$30.3M $38.25 76
2018 Q1 23.7M $949M +$61.1M $40.10 79
2017 Q4 22.2M $780M +$59.9M $35.10 72
2017 Q3 20.5M $446M +$25.4M $21.75 58
2017 Q2 19.3M $359M +$66.1M $18.60 55
2017 Q1 15.7M $432M +$32.8M $27.50 49
2016 Q4 14.8M $388M +$18.1M $26.15 50
2016 Q3 14.1M $457M -$3.4M $32.47 44
2016 Q2 14.2M $294M +$6.8M $20.69 37
2016 Q1 14M $192M +$2.93M $13.88 22
2015 Q4 13.8M $219M +$83.2M $15.95 17